Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data

OBJECTIVE: This study was undertaken to evaluate the long-term clinical efficacy of epoetin alfa and darbepoetin alfa in patients with myelodysplastic syndrome (MDS) in a real-life setting. MATERIALS AND METHODS: A total of 204 patients with low-risk or intermediate-1-risk MDS who received epoetin a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslaner Ak, Müzeyyen, Gedük, Ayfer, Acar, İbrahim Halil, Polat, Merve Gökçen, Sunu, Cenk, Bolaman, Ali Zahit, Hacıbekiroğlu, Tuğba, Güvenç, Birol, Ertop, Şehmus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240155/
https://www.ncbi.nlm.nih.gov/pubmed/36799095
http://dx.doi.org/10.4274/tjh.galenos.2023.2022.0437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240155/
https://www.ncbi.nlm.nih.gov/pubmed/36799095
http://dx.doi.org/10.4274/tjh.galenos.2023.2022.0437

Ejemplares similares